EN BREF ...
"The main aim of this series of reports is to provide a comprehensive overview of the industry landscape in what pertains adoption of AI in drug discovery, clinical research and other aspects of pharmaceutical R&D. This overview highlights trends and insights in a form of informative mind maps and infographics as well as benchmarks the performance of key players that form the space and relations within the industry. This is an overview analysis to help the reader understand what is happening in the industry nowadays and possibly give an idea of what is coming next. The lists of AI-biotech companies, biotech investors, and pharma organizations have been expanded to include new entities, and a new list of leading contract research organizations (CROs) has been added to outline the growing interest of contract research industry in the advanced data analytics technologies." En bref issu de l'étude.
Rédacteur(s) de la fiche : Beesens TEAM
Introductio
1 - In tincidunt nunc ac velit tristique
- Pellentesque congue, magna elementum suscipit vestibulum
- Aenean eleifend sodales ipsum vitae consequat
- Quisque est leo tempus vel purus eu, placerat tincidunt nisl
2 - Sed lobortis elit vitae mollis consectetur
- In tincidunt nunc ac velit tristique
- Donec accumsan elit ac ornare eleifend
- Sed pellentesque suscipit quam ut finibus
- Fusce imperdiet neque sit amet ipsum ullamcorper scelerisque
3 - Lorem ipsum dolor sit amet
- Pellentesque congue, magna elementum suscipit vestibulum
- Aenean eleifend sodales ipsum vitae consequat
- Quisque est leo tempus vel purus eu, placerat tincidunt nisl
Conclusio
Pour accéder à ce contenu,
créez votre compte
gratuitement
Accéder à :
- L'ensemble de la veille e-santé sélectionnée
par la communauté Beesens, - Des documents de références de la e-santé,
- Et bien plus encore...
Déjà inscrit ? Identifiez-vous